Evidence map›Paper›PMID 39372056›Full record

ArticleRSC advances2024

Up-converting β-NaY

M Parvizian, W Mnasri, M Pleckaitis, V Karabanovas, H Khan, S Nowak, S Gam-Derouich, L Ben Tahar, O Sandre, R Rotomskis and 1 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

M ParvizianUniversité Paris Cité, ITODYS, CNRS UMR-7086 Paris 75205 France souad.ammar- merah@u-paris.fr.
W MnasriUniversité Paris Cité, ITODYS, CNRS UMR-7086 Paris 75205 France souad.ammar- merah@u-paris.fr.ORCID https://orcid.org/0009-0003-0952-592X
M PleckaitisNational Cancer Institute, Biomedical Physics Laboratory Vilnius 08406 Lithuania.ORCID https://orcid.org/0000-0001-7570-3278
V KarabanovasNational Cancer Institute, Biomedical Physics Laboratory Vilnius 08406 Lithuania.ORCID https://orcid.org/0000-0002-5029-8840
H KhanUniversité Paris Cité, ITODYS, CNRS UMR-7086 Paris 75205 France souad.ammar- merah@u-paris.fr.
S NowakUniversité Paris Cité, ITODYS, CNRS UMR-7086 Paris 75205 France souad.ammar- merah@u-paris.fr.
S Gam-DerouichUniversité Paris Cité, ITODYS, CNRS UMR-7086 Paris 75205 France souad.ammar- merah@u-paris.fr.
L Ben TaharUniversité de Carthage, Faculté des Sciences de Bizerte, Laboratoire Synthèse et Structure des Nanomatériaux Zarzouna 7021 Tunisia.ORCID https://orcid.org/0000-0003-1856-8094
O SandreUniv. Bordeaux, CNRS Bordeaux INP, UMR-5629, LCPO Pessac 33607 France.ORCID https://orcid.org/0000-0002-1815-2702
R RotomskisNational Cancer Institute, Biomedical Physics Laboratory Vilnius 08406 Lithuania.ORCID https://orcid.org/0000-0003-0825-4884
S AmmarUniversité Paris Cité, ITODYS, CNRS UMR-7086 Paris 75205 France souad.ammar- merah@u-paris.fr.ORCID https://orcid.org/0000-0002-1656-0016

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current biomedical imaging techniques are vital for the diagnosis of various diseases. They are related to the development of multimodal probes encompassing all the functionalities required for comprehensive imaging. In this context, we applied a simple and reproducible wet synthesis route to produce such probes. This method allowed us to prepare about 100 nm sized lanthanide-doped yttrium fluoride nanoparticles β-NaY

Identifiers

PMID39372056
PMCPMC11450549

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.